go back

Ranibizumab (Susvimo) Sustained-Release Implant

Utah rates for HCPCS C9093

Injection, ranibizumab, via sustained release intravitreal implant (Susvimo), 0.1 mg

Rates data updated July 2026.

Facilitymedian $79 · 10th–90th $79$790%50%100%$79Professionalmedian $79 · 10th–90th $79$790%50%100%$79

Distribution of negotiated rates across all payers (price axis is log-scale). Facility and professional rates are different services and are charted separately. Need provider-level prices? Contact us.

Insurance Carrier
Aetna
Setting
Facility
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$79.43
Aetna
Setting
Professional
Modifier
Global
Typical Low
$79.43
Median
$79.43
Typical High
$79.43